German Labs Partner to Investigate 454 FLX, GS Junior for Diagnostic Sequencing

“We strongly believe that diagnostic sequencing will rapidly adopt the high-throughput technologies used now for genomic research," said Hanns-Georg Klein, CEO of both IMGM and the Center for Human Genetics and Laboratory Medicine.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.